Neurocrine Biosciences' valbenazine shows promise as an adjunctive therapy for Schizophrenia, with phase 3 data expected in ...

Are substance-induced psychosis and primary psychosis fundamentally different? And if they are, does it matter?

Individuals who sought hospital care or emergency treatment due to cannabis use showed a higher likelihood of developing ...

Across Pennsylvania, families like those of Cody Balmer's, the suspect in the firebombing at the Governor's Residence, ...

The man behind the Aug. 10, 2018, Fredericton shootings has made progress at the Restigouche Hospital Centre, the psychiatric ...

引言2025年3月29日至4月2日，备受全球关注的精神分裂症国际研究学会大会 (SIRS) 在美国芝加哥举行。此次会议聚焦精神分裂症领域的最新进展及未来发展路径。作为该领域最具权威性的学术活动之一，SIRS 大会不仅为研究人员提供了分享前沿成果的机会 ...

It completely altered my life,” says one woman who ate a single THC gummy before watching a movie at home. “My surroundings ...

Find out how LB Pharmaceuticals’ LB-102 is advancing schizophrenia treatment. This first-in-class antipsychotic demonstrates strong efficacy, safety and tolerability, potentially addressing both acute ...

Kidney disease is strongly linked with cardiovascular diseases, hypertension, diabetes, infections and other health conditions, as well as social determinants of health and climate change.

Could this be a new avenue for understanding #schizophrenia? #Neuroscience #MentalHealthResearch’ This rodent study examined changes in proteins essential for myelin production (myelination).